CD274 and neoplasm: In the KEYNOTE studies, the 22C3 pharmDx assay was used to evaluate TPS (percentage of tumor cells with positive membranous PD‐L1 staining), while in the IMpower studies, the SP142 assay was used to detect PD‐L1 expression on tumor cells and tumor‐infiltrating immune cells.